Crescent Capital BDC (NASDAQ: CCAP) CEO and President join board

Rhea-AI Filing Summary

FAQ

Filing Exhibits & Attachments

8-K Event Classification

Key Figures

Key Terms

What board changes did Crescent Capital BDC (CCAP) announce in this 8-K?

Why did Elizabeth Ko resign from Crescent Capital BDC’s board?

What roles will Jason Breaux hold at Crescent Capital BDC after this filing?

What is Henry Chung’s new position at Crescent Capital BDC?

Will Crescent Capital BDC’s new directors receive additional compensation?

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Crescent Capital BDC, Inc. reported board changes. Effective May 5, 2026, the board accepted the resignation of Class III director Elizabeth Ko, who stated her decision was not due to any disagreement with management, the board, or company operations.

Effective May 7, 2026, the board elected Chief Executive Officer Jason Breaux and President Henry Chung as Class III directors, whose terms run until the 2027 annual meeting or until successors are elected and qualified. Breaux will serve as Chairman of the Board. Neither Breaux nor Chung will receive compensation or equity awards for board service, and both will continue in their existing executive roles.

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Director resignation effective date: May 5, 2026 New director election date: May 7, 2026 Notes due: 5.00% Notes due 2026 +1 more

4 metrics

Director resignation effective date May 5, 2026 Effective resignation date of Class III director Elizabeth Ko

New director election date May 7, 2026 Effective election date for Jason Breaux and Henry Chung as Class III directors

Notes due 5.00% Notes due 2026 Debt security listed as registered under Section 12(b)

Par value per share $0.001 per share Par value of Crescent Capital BDC common stock

Class III director, Chairman of the Board, investment committee, Emerging growth company, +1 more

5 terms

Class III director financial

"the Board elected Mr. Jason Breaux as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting"

A Class III director is a board member placed in one of the numbered groups used by companies with a staggered (or “classified”) board; that director’s seat typically comes up for election in the third year of a three-year rotation. For investors this matters because staggered terms create continuity but also make it harder to replace the whole board quickly, affecting shareholder influence, takeover dynamics and how fast new strategy or accountability can be implemented — like replacing only some players on a sports team each season instead of the whole roster at once.

Chairman of the Board financial

"Mr. Breaux, who will serve as Chairman of the Board, will not receive any compensation or equity awards"

Chairman of the board is the person who leads a company’s board of directors, setting meeting agendas, guiding discussions and ensuring the board supervises management’s strategy and risk decisions. Investors care because the chair’s leadership and style influence how well shareholder interests are protected, how quickly strategic choices are made, and the company’s overall accountability—like a team captain shaping group performance.

investment committee financial

"Mr. Breaux also serves as Chairman of the investment committee of the Company’s investment adviser"

An investment committee is a small group of experienced people who set the rules and make the key decisions about what investments to buy, hold, or sell for a fund, pension, or portfolio. Think of them as the steering team that balances goals, potential returns and risk—their choices shape how much money investors are likely to gain or lose and provide consistent oversight so decisions aren’t made impulsively.

Emerging growth company regulatory

"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Annual Meeting of Stockholders financial

"which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders"

Understanding 8-K Material Events →

05/08/2026 - 04:05 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 8, 2026, (May 6, 2026)

Crescent Capital BDC, Inc.

(Exact name of registrant as specified in its charter)

Maryland

814-01132

47-3162282

(State or Other Jurisdiction

of Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


11100 Santa Monica Blvd., Suite 2000,
Los Angeles, CA		90025
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (310) 235-5900

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to 12(b) of the Act:

Securities registered pursuant to Section 12(g) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.001 par value per share	CCAP	The Nasdaq Stock Market LLC
5.00% Notes due 2026	FCRX	The New York Stock Exchange
	Common Stock, par value $0.001 per share
	(Title of class)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Departure of Director.

On and effective as of 12:00 a.m. midnight on May 5, 2026, the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Elizabeth Ko as a member of the Board and a Class III Director. Ms. Ko did not serve on any committees of the Board. Ms. Ko’s decision to resign was not the result of any disagreement with management or the Board, or related to the Company’s operations, policies or practices. The Company and its Board appreciate the support and guidance Ms. Ko has provided as a member of the Board.

(d) Election of Director.

On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Jason Breaux as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified. Mr. Breaux, who will serve as Chairman of the Board, will not receive any compensation or equity awards for his service as a director. Mr. Breaux has not been named to serve on any committee of the Board.

Mr. Breaux has served as Chief Executive Officer of the Company since 2015 and will continue to serve as Chief Executive Officer. Mr. Breaux also serves as Chairman of the investment committee of the Company’s investment adviser. In addition, Mr. Breaux serves as Managing Director and Head of Private Credit of Crescent Capital Group LP (“Crescent”) and is a member of Crescent’s Operating Committee. Prior to joining Crescent in 2000, he worked at Roberston Stephens where he served in the mergers and acquisitions group. Prior to that, he worked in the investment banking division of Salomon Brothers. Mr. Breaux received an MBA from the Darden School of Business at the University of Virginia and an AB from Georgetown University.

On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Henry Chung as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified. Mr. Chung will not receive any compensation or equity awards for his service as a director. Mr. Chung has not been named to serve on any committee of the Board.

Mr. Chung has served as President of the Company since 2024 and will continue to serve as President. Mr. Chung also serves as a Managing Director of Crescent, focusing on private credit. Prior to joining Crescent in 2015, he worked at Imperial Capital, where he was a member of the Corporate Finance division. Prior to that, he worked at Trinity Capital. Mr. Chung received a BA in Philosophy from the University of California, Los Angeles.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

Source: View Original Filing on SEC EDGAR

Crescent Capital BDC announced that Class III director Elizabeth Ko resigned effective May 5, 2026. On May 7, 2026, the board elected CEO Jason Breaux and President Henry Chung as Class III directors, with Breaux also becoming Chairman of the Board.

Elizabeth Ko resigned as a Class III director effective May 5, 2026. The company states her decision was not due to any disagreement with management, the board, or the company’s operations, policies, or practices, indicating a non-contentious departure from the board.

Jason Breaux will serve as both Chief Executive Officer and Chairman of the Board, and as a Class III director. He also remains Chairman of the investment committee of the company’s adviser and continues his Managing Director and Head of Private Credit role at Crescent Capital Group LP.

Henry Chung has been elected a Class III director effective May 7, 2026, while continuing as President of Crescent Capital BDC. He will not receive compensation or equity awards for board service and also continues as a Managing Director at Crescent focusing on private credit.

The filing states that both Jason Breaux and Henry Chung will not receive any compensation or equity awards for their service as directors. They continue in their existing executive roles at Crescent Capital BDC without incremental board-related pay under this change.

CRESCENT CAPITAL BDC, INC.

Date: May 8, 2026

/s/ Jason Breaux

Jason Breaux

Chief Executive Officer

4 documents